Filing Details

Accession Number:
0001209191-14-072053
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-01 19:50:14
Reporting Period:
2014-11-26
Filing Date:
2014-12-01
Accepted Time:
2014-12-01 19:50:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1571820 Sanjay Chanda C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
Svp, Drug Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-26 5,000 $7.25 8,995 No 4 M Direct
Common Stock Disposition 2014-11-26 5,000 $35.00 3,995 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-11-26 5,000 $7.25 5,000 $7.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,952 2018-03-26 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2014, and as amended on September 12, 2014.
  2. This option is fully vested and exercisable.